Roundview Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.67M | Buy |
30,467
+618
| +2% | +$133K | 0.42% | 61 |
|
|
2026
Q1 | $6.49M | Buy |
29,849
+362
| +1% | +$80.3K | 0.4% | 60 |
|
|
2025
Q4 | $6.74M | Buy |
29,487
+86
| +0.3% | +$19.6K | 0.41% | 57 |
|
|
2025
Q3 | $6.81M | Buy |
29,401
+151
| +0.5% | +$30.7K | 0.43% | 53 |
|
|
2025
Q2 | $5.43M | Buy |
29,250
+329
| +1% | +$61.1K | 0.36% | 63 |
|
|
2025
Q1 | $6.06M | Buy |
28,921
+201
| +0.7% | +$39.1K | 0.44% | 54 |
|
|
2024
Q4 | $5.1M | Buy |
28,720
+765
| +3% | +$141K | 0.36% | 65 |
|
|
2024
Q3 | $5.52M | Buy |
27,955
+87
| +0.3% | +$16.2K | 0.4% | 60 |
|
|
2024
Q2 | $4.78M | Buy |
27,868
+428
| +2% | +$70.9K | 0.38% | 60 |
|
|
2024
Q1 | $5M | Buy |
27,440
+722
| +3% | +$124K | 0.41% | 58 |
|
|
2023
Q4 | $4.14M | Sell |
26,718
-5,554
| -17% | -$810K | 0.38% | 59 |
|
|
2023
Q3 | $4.81M | Sell |
32,272
-56
| -0.2% | -$8.22K | 0.48% | 50 |
|
|
2023
Q2 | $4.36M | Buy |
32,328
+99
| +0.3% | +$14.5K | 0.43% | 57 |
|
|
2023
Q1 | $5.14M | Buy |
32,229
+331
| +1% | +$50.6K | 0.54% | 49 |
|
|
2022
Q4 | $5.16M | Buy |
31,898
+442
| +1% | +$67.8K | 0.59% | 46 |
|
|
2022
Q3 | $4.22M | Buy |
31,456
+501
| +2% | +$71.9K | 0.53% | 48 |
|
|
2022
Q2 | $4.74M | Buy |
30,955
+218
| +0.7% | +$33.3K | 0.57% | 44 |
|
|
2022
Q1 | $4.98M | Sell |
30,737
-4,657
| -13% | -$676K | 0.51% | 52 |
|
|
2021
Q4 | $4.79M | Sell |
35,394
-271
| -0.8% | -$32K | 0.48% | 50 |
|
|
2021
Q3 | $3.85M | Buy |
35,665
+1,584
| +5% | +$181K | 0.42% | 58 |
|
|
2021
Q2 | $3.84M | Buy |
34,081
+3,644
| +12% | +$410K | 0.43% | 64 |
|
|
2021
Q1 | $3.29M | Sell |
30,437
-5,808
| -16% | -$621K | 0.41% | 68 |
|
|
2020
Q4 | $3.88M | Sell |
36,245
-6,257
| -15% | -$601K | 0.53% | 45 |
|
|
2020
Q3 | $3.72M | Sell |
42,502
-10,800
| -20% | -$1.02M | 0.58% | 46 |
|
|
2020
Q2 | $5.23M | Buy |
53,302
+7,831
| +17% | +$689K | 0.89% | 26 |
|
|
2020
Q1 | $3.46M | Buy |
45,471
+16,038
| +54% | +$1.37M | 0.73% | 33 |
|
|
2019
Q4 | $2.61M | Buy |
29,433
+15,548
| +112% | +$1.29M | 0.5% | 57 |
|
|
2019
Q3 | $1.05M | Buy |
13,885
+3,748
| +37% | +$257K | 0.23% | 123 |
|
|
2019
Q2 | $738K | Sell |
10,137
-1,054
| -9% | -$82.8K | 0.17% | 147 |
|
|
2019
Q1 | $902K | Buy |
11,191
+338
| +3% | +$27.7K | 0.21% | 122 |
|
|
2018
Q4 | $1M | Buy |
10,853
+470
| +5% | +$41.3K | 0.28% | 97 |
|
|
2018
Q3 | $982K | Buy |
10,383
+1,577
| +18% | +$150K | 0.24% | 115 |
|
|
2018
Q2 | $816K | Sell |
8,806
-45
| -0.5% | -$4.39K | 0.21% | 127 |
|
|
2018
Q1 | $838K | Sell |
8,851
-5,636
| -39% | -$619K | 0.24% | 117 |
|
|
2017
Q4 | $1.4M | Sell |
14,487
-224
| -2% | -$21.1K | 0.36% | 87 |
|
|
2017
Q3 | $1.31M | Buy |
14,711
+6,400
| +77% | +$487K | 0.37% | 83 |
|
|
2017
Q2 | $603K | Sell |
8,311
-22,265
| -73% | -$1.5M | 0.18% | 145 |
|
|
2017
Q1 | $1.99M | Sell |
30,576
-4,000
| -12% | -$251K | 0.62% | 53 |
|
|
2016
Q4 | $2.17M | Sell |
34,576
-3,200
| -8% | -$195K | 0.69% | 40 |
|
|
2016
Q3 | $2.38M | Sell |
37,776
-400
| -1% | -$25.9K | 0.84% | 33 |
|
|
2016
Q2 | $2.36M | Sell |
38,176
-150
| -0.4% | -$9.14K | 0.87% | 32 |
|
|
2016
Q1 | $2.19M | Sell |
38,326
-2,337
| -6% | -$130K | 0.82% | 34 |
|
|
2015
Q4 | $2.41M | Buy |
40,663
+13,000
| +47% | +$749K | 0.95% | 23 |
|
|
2015
Q3 | $1.5M | Buy |
27,663
+21,575
| +354% | +$1.4M | 0.65% | 44 |
|
|
2015
Q2 | $409K | Buy |
6,088
+1,471
| +32% | +$96K | 0.15% | 116 |
|
|
2015
Q1 | $270K | Hold |
4,617
| – | – | 0.11% | 135 |
|
|
2014
Q4 | $302K | Hold |
4,617
| – | – | 0.12% | 125 |
|
|
2014
Q3 | $267K | Hold |
4,617
| – | – | 0.12% | 112 |
|
|
2014
Q2 | $261K | Hold |
4,617
| – | – | 0.11% | 135 |
|
|
2014
Q1 | $237K | Hold |
4,617
| – | – | 0.12% | 117 |
|
|
2013
Q4 | $244K | Sell |
4,617
-100
| -2% | -$4.92K | 0.11% | 119 |
|
|
2013
Q3 | $211K | Buy |
+4,717
| New | +$209K | 0.11% | 117 |
|
Other funds holding ABBV
Roundview Capital's ABBV Position: Q2 2026 in Review
Roundview Capital increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $133K and bringing the position to 30,467 shares worth $7.67M. The position accounts for 0.42% of the portfolio, ranked #61.
Roundview Capital first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Roundview Capital held 30,467 shares of AbbVie worth $7.67M as of Q2 2026.
- Roundview Capital bought 618 AbbVie shares in Q2 2026, an estimated $133K.
- AbbVie made up 0.42% of Roundview Capital's portfolio in Q2 2026, its #61 holding.
- Roundview Capital first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Roundview Capital's 13F filing for Q2 2026, filed 30 Jul 2026.